Company Overview of Celgene Avilomics Research, Inc.
Celgene Avilomics Research, Inc., a clinical-stage biotechnology company, focuses on the design and development of targeted covalent drugs. Its product candidate CC-292, a treatment for cancer and autoimmune diseases is in phase I clinical testing. Celgene Avilomics Research, Inc. was formerly known as Avila Therapeutics, Inc. and changed its name to Celgene Avilomics Research, Inc. in June 2012. The company was incorporated in 2006 and is based in Waltham, Massachusetts. As of March 7, 2012, Celgene Avilomics Research, Inc. operates as a subsidiary of Celgene Corporation.
100 Beaver Street
Waltham, MA 02453-8425
Founded in 2006
Key Executives for Celgene Avilomics Research, Inc.
Similar Private Companies By Industry
|Cyteir Therapeutics, Inc.||United States|
|NapaJen Corporation||United States|
|Midland Bioproducts Corporation||United States|
|DryLet, LLC||United States|
|RadioPharmacy Investors, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Celgene Avilomics Research, Inc., please visit www.celgene.com/research-development/rd-locations/avilomics-research/. Company data is provided by Capital IQ. Please use this form to report any data issues.